Purpose: To compare the vocal tract configuration between male speakers with Class III malocclusion and their normally developing counterparts and to investigate the concomitant acoustic changes caused by the alterations in vocal tract configuration.

Patients And Methods: Eight young male patients with Class III malocclusion and 8 normally developing counterparts participated in this study. Acoustic reflection technology was used to measure vocal tract dimensions in the 2 groups. A continuous speech sample and 4 sustained vowels (/a/, /æ/, /i/, and /u/) were recorded from each participant to obtain the fundamental frequency and the first 3 formant frequencies (F1, F2, and F3).

Results: The results showed significantly greater oral length and oral volume for young male patients with Class III malocclusion than their cohorts. The F1 of vowel /u/ was found to be significantly higher in male patients with Class III malocclusion than their cohorts. The vowel space of the 4 recorded vowels was reduced and the F1-F2 formant map for /u/ was relatively more scattered in male patients with Class III malocclusion than in the control speakers.

Conclusion: This study has provided preliminary information on the effects of Class III malocclusion on vocal tract configuration and concomitant acoustic changes in young male patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.joms.2010.02.038DOI Listing

Publication Analysis

Top Keywords

class iii
28
iii malocclusion
28
vocal tract
20
male patients
20
young male
16
patients class
16
effects class
8
tract configuration
8
malocclusion developing
8
developing counterparts
8

Similar Publications

Background And Objectives: Safety and efficacy of IV onasemnogene abeparvovec has been demonstrated for patients with spinal muscular atrophy (SMA) weighing <8.5 kg. SMART was the first clinical trial to evaluate onasemnogene abeparvovec for participants weighing 8.

View Article and Find Full Text PDF

A Chromatography Test Strip of Exonuclease III-Amplified Aptamer for Rapid Identification of Prorocentrum minimum.

Mar Biotechnol (NY)

January 2025

School of Marine Science and Technology, Harbin Institute of Technology (Weihai), Wenhua West Road, 2#, Weihai, 264209, People's Republic of China.

Recently, the scale and frequency of harmful algae blooms (HABs) have gradually increased, posing a serious threat to human health, marine ecosystems and economic development. For early warning, a method is required that can quickly detect and monitor microalgae. It is proposed to use aptamer targeted to Prorocentrum minimum, along with exonuclease III (Exo III), gold nanoparticles, target single-stranded DNA and hairpin structure probe to construct a new method, i.

View Article and Find Full Text PDF

Allergic Reactivity and Memory Occur Independently of Sequential Switching Through IgG1.

Allergy

January 2025

Schroeder Allergy and Immunology Research Institute, Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Canada.

Allergic reactions to foods are primarily driven by allergen-binding immunoglobulin (Ig)E antibodies. IgE-expressing cells can be generated through direct switching from IgM to IgE or a sequential class switching pathway where activated B cells first switch to an intermediary isotype, most frequently IgG1, and then to IgE. It has been proposed that sequential class switch recombination is involved in augmenting the severity of allergic reactions, generating high affinity IgE, differentiation of IgE plasma cells, and in holding the memory of IgE responses.

View Article and Find Full Text PDF

Introduction: Previous guidelines considered body mass index (BMI) over 40 kg/m a relative contra-indication to liver transplantation (LT). The aims were to examine the selection process and study outcomes of patients with Class I-III obesity.

Methods: Retrospective analysis of outcomes of obese patients assessed for LT at our center between 2010 and 2023, divided into three groups: Class I (BMI30-34.

View Article and Find Full Text PDF

Tuberculosis (TB) is historically the world's deadliest infectious disease. New TB drugs that can avoid pre-existing resistance are desperately needed. The β-lactams are the oldest and most widely used class of antibiotics to treat bacterial infections but, for a variety of reasons, they were largely ignored until recently as a potential treatment option for TB.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!